Princeton Global Asset Management LLC G1 Therapeutics, Inc. Transaction History

Princeton Global Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$4.04 - $8.51 $6,060 - $12,765	-1,500 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$13.16 - $22.47 $19,476 - $33,255	1,480 Added 7400.0%	1,500 $20,000
Q3 2021 Nov 03, 2021	SELL	$13.16 - $22.47 $19,476 - $33,255	-1,480 Reduced 98.67%	20 $20,000
Q1 2021 May 11, 2021	BUY	$17.58 - $32.59 $17,580 - $32,590	1,000 Added 200.0%	1,500 $36,000
Q4 2020 Feb 09, 2021	BUY	$10.99 - $20.4 $5,495 - $10,200	500 New	500 $9,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Princeton Global Asset Management LLC with notifications on news.